European Survey of 8,688 Adults Finds 54-64% Back State-Funded Fertility Care Across Four Nations

The 2026 ESHRE-linked poll sampled over 2,000 adults per country on attitudes toward IVF access, embryo research, genome editing and the 14-day rule. Support for state-funded care ranged 54% (Netherlands) to 64% (Italy); backing for embryo research to study congenital disease reached 41-48%, exceeding opposition everywhere including Italy where such work remains banned. These figures emerge against Europe’s sustained sub-replacement fertility rates (Eurostat 2024: 1.46 EU average) and widening gaps in treatment access between public and private systems.

Unlike U.S. coverage that frames reproductive policy mainly through abortion litigation, the data reveal cross-national appetite for treating infertility as a public-health responsibility rather than a consumer good. Generational splits—younger cohorts more open to genome editing for severe disease—track similar patterns in recent UK and Dutch parliamentary debates on mitochondrial donation. The survey also flags persistent uncertainty: 27% could not judge the 14-day limit, suggesting information gaps that regulators will confront if extension proposals advance.

The findings imply political space for harmonized EU-level guidance on funding thresholds and research boundaries that has so far received minimal transatlantic attention. Next steps include national replication studies with larger clinical cohorts and linkage to actual utilization data from public IVF registries to test whether stated support predicts uptake or voting behavior.